Cervical Intraepithelial Neoplasia
"Cervical Intraepithelial Neoplasia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignancy arising in uterine cervical epithelium and confined thereto, representing a continuum of histological changes ranging from well-differentiated CIN 1 (formerly, mild dysplasia) to severe dysplasia/carcinoma in situ, CIN 3. The lesion arises at the squamocolumnar cell junction at the transformation zone of the endocervical canal, with a variable tendency to develop invasive epidermoid carcinoma, a tendency that is enhanced by concomitant human papillomaviral infection. (Segen, Dictionary of Modern Medicine, 1992)
|Cervical Intraepithelial Neoplasia
- Cervical Intraepithelial Neoplasia
- Neoplasia, Cervical Intraepithelial
- Cervical Intraepithelial Neoplasms
- Cervical Intraepithelial Neoplasm
- Intraepithelial Neoplasm, Cervical
- Intraepithelial Neoplasms, Cervical
- Neoplasm, Cervical Intraepithelial
- Neoplasms, Cervical Intraepithelial
- Intraepithelial Neoplasia, Cervical
Below are MeSH descriptors whose meaning is more general than "Cervical Intraepithelial Neoplasia".
Below are MeSH descriptors whose meaning is more specific than "Cervical Intraepithelial Neoplasia".
This graph shows the total number of publications written about "Cervical Intraepithelial Neoplasia" by people in this website by year, and whether "Cervical Intraepithelial Neoplasia" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Cervical Intraepithelial Neoplasia" by people in Profiles.
Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FAR, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstet Gynecol. 2015 Feb; 125(2):330-337.
Castle PE, Smith KM, Davis TE, Schmeler KM, Ferris DG, Savage AH, Gray JE, Stoler MH, Wright TC, Ferenczy A, Einstein MH. Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population. Am J Clin Pathol. 2015 Jan; 143(1):126-33.
Nolte FS, Ribeiro-Nesbitt DG. Comparison of the Aptima and Cervista tests for detection of high-risk human papillomavirus in cervical cytology specimens. Am J Clin Pathol. 2014 Oct; 142(4):561-6.
Savage AH, Marlow NM, Alkis MH, Simpson KN. Cost-effectiveness analysis of 2 surveillance options for cervical intraepithelial neoplasia 1. J Low Genit Tract Dis. 2014 Apr; 18(2):136-41.
Guo M, Baruch AC, Silva EG, Jan YJ, Lin E, Sneige N, Deavers MT. Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma. Am J Clin Pathol. 2011 Feb; 135(2):212-20.
Bynum SA, Wright MS, Brandt HM, Burgis JT, Bacon JL. Knowledge, beliefs, and attitudes related to human papillomavirus infection and vaccination, pap tests, and cervical intraepithelial neoplasia among adolescent girls and young women. J S C Med Assoc. 2009 Dec; 105(7):267-72.
Yoost JL, Goetzl L, Hoda R, Soper DE, Barry A. Management of the low grade squamous intraepithelial lesion Pap smear in a cross-sectional, observational cohort. J Reprod Med. 2009 Jul; 54(7):421-4.
Young JL, Jazaeri AA, Darus CJ, Modesitt SC. Cyclooxygenase-2 in cervical neoplasia: a review. Gynecol Oncol. 2008 Apr; 109(1):140-5.
Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, Heintz AP, Ngan HY, Pecorelli S. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S43-103.
Mathur SP, Mathur RS, Gray EA, Lane D, Underwood PG, Kohler M, Creasman WT. Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected]. Gynecol Oncol. 2005 Sep; 98(3):467-83.